NASDAQ · Medical - Devices

IceCure Medical Ltd. (ICCM) Stock

$1.10 -2.65% NASDAQ: ICCM Healthcare

Valuation

MetricValue
Price$1.10
Market Cap$2.48M
P/E Ratio-0.23
P/B Ratio0.41
P/S Ratio0.90
EPS (TTM)$-0.24
52-Week High$33.00
52-Week Low$1.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-174.26%
ROA-95.33%
ROCE-184.27%
Gross Margin-500.00%
Operating Margin-500.00%
Net Margin-427.67%
Debt/Equity0.01
Current Ratio2.60

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.0M$3.0M$3.0M$3.0M$3.0M
Operating Profit$-10.0M$-17.0M$-16.0M$-16.0M$-15.0M
Net Profit$-10.0M$-17.0M$-15.0M$-15.0M$-15.0M
EPS$-10.20$-13.69$-9.60$-9.00$-7.10
Op Margin-235.0%-542.6%-482.4%-476.9%-446.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$32.0M$30.0M$16.0M$13.0M$14.0M
Total Liabilities$5.0M$5.0M$4.0M$6.0M$5.0M
Cash$26.0M$24.0M$11.0M$8.0M$9.0M
Borrowings$1.0M$1.0M$1.0M$0$0

Latest News

IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation PR Newswire · Jul 14, 2026 IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer PR Newswire · Jul 6, 2026 IceCure Medical Files to Register Sale of 5.5 Million Shares by Armistice MT Newswires · Jun 25, 2026 IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire · Jun 25, 2026 IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer PR Newswire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-14.0M$-13.0M$-13.0M$-15.0M
Investing Cash Flow$3.0M$-2.0M$-1.0M$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$22.0M$-2.0M$-13.0M$-3.0M$1.0M
Free Cash Flow$-13.0M$-15.0M$-13.0M$-13.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA0.51
FCF Yield-463.53%
Quick Ratio2.44
Interest Coverage-139.87
Return 1Y-88.12%
Return 3Y-90.91%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About IceCure Medical Ltd.

IceCure Medical Ltd. is led by CEO Eyal Shamir, employs 64 people, headquartered in IL, publicly traded since 2021.

IceCure Medical Ltd. (ICCM) stock trades at $1.10 with a market capitalization of $2.48M. The stock is valued at a price-to-earnings (P/E) ratio of -0.23, price-to-book of 0.41, price-to-sales of 0.90. Over the past 52 weeks the stock has ranged between $1.06 and $33.00, and currently trades 96.7% below its 52-week high.

On profitability, IceCure Medical Ltd. generates a return on equity (ROE) of -174.26%, return on capital employed of -184.27%, an operating margin of -500.00%, a net profit margin of -427.67%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides